產(chǎn)品分類(lèi)
Phospholipids
PEG Derivatives
Block Copolymers
Gold Nanoparticles
Fe3O4 Magnetic nano
Fluorescent dyes
Protein Crosslinkers
Monodispersed PEGs
Click chemistry
Medicinal polymer
APIs cancer
Fluorescence quantum dot
MRI imaging
Microspheres
PROTAC技術(shù)
semiconductor
Synthetic chemistry
Nano drug delivery
Others
快速訂購(gòu)
31952518
  • 029-86354885
  • 18392009562
Home > Products > APIs cancer> Hot APIs cancer> XL880; Foretinib; GSK136308,CAS849217-64-7
XL880; Foretinib; GSK136308,CAS849217-64-7
Catalog # Pkg Size Price Quantity Shopping Cart
R-SX-132 1 ￥ 1
加入購(gòu)物車(chē)
結(jié)構(gòu)式
外觀 N/A
分子量 632.65376
溶解度 N/A
CAS號(hào) 849217-64-7
質(zhì)量控制 N/A
儲(chǔ)存條件 N/A
保存時(shí)間 N/A
其他信息 價(jià)格1，就是價(jià)格現(xiàn)詢(xún)
Foretinib (GSK1363089) is an ATP-competitive inhibitor of HGFR and VEGFR, mostly for Met and KDR with IC50 of 0.4 nM and 0.9 nM in cell-free assays. Less potent against Ron, Flt-1/3/4, Kit, PDGFRα/β and Tie-2, and little activity to FGFR1 and EGFR. Phase 2.西安瑞禧生物提供各種抑制劑材料。
親，說(shuō)點(diǎn)什么吧，您的評(píng)價(jià)對(duì)其它買(mǎi)家很有幫助哦~
“好評(píng)，中評(píng)，差評(píng)”請(qǐng)?zhí)顚?xiě)其一哦~
您的昵稱(chēng)

合作品牌
?
庫(kù)存查詢(xún)